No Elevated Risk for Osteoporosis or Osteopenia Among Women With Androgenetic or Frontal Fibrosing Alopecia Treated With 5-Alpha Reductase Inhibitors: A Retrospective TriNetX Cohort Study

    Daniela Mendez, Marc Hill, Melissa Piliang, Wilma Bergfeld
    Studysummary 5-alpha reductase inhibitors do not increase osteoporosis risk in women with certain hair loss conditions.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jaad.org →
    Discuss this study in the Community →

    Research cited in this study 1

    1. A Population-Based Study of the Risk of Osteoporosis and Fracture with Dutasteride and Finasteride BMC Musculoskeletal Disorders · 2018